Study Once More Underpins the Clinical Value of FDA-cleared Breast Cancer Recurrence Assay IRVINE, CA, and AMSTERDAM, THE NETHERLANDS – Agendia, a world leader in molecular cancer diagnostics, announced today that together with several groups of scientific collaborators it has identified a major role for TSPYL5, one of its MammaPrint breast cancer prognosis genes, in […]
Certification allows Spartan RX CYP2C19 to be distributed in select countries across Europe, Middle East, Africa, Latin America, and Asia Pacific OTTAWA, ON – Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced its Spartan RX CYP2C19 received a CE IVD Mark […]
ISCA CNV atlas Leuven, Belgium – Cartagenia announced today that it has signed an agreement with the International Standards for Cytogenomic Arrays (ISCA) Consortium to set up an automated data acquisition pipeline based on Cartagenia’s BENCH data management solution. The CNV Atlas project aims to build a database of abnormal regions of the genome – […]
Fremont, Calif., and Luxembourg – WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, and the Integrated BioBank of Luxembourg (IBBL) today announced an agreement to establish a strategic relationship that will expand the use of the WaferGen SmartChip Real-Time PCR system throughout Europe and advance personalized medicine. The agreement includes: •The […]
Goal Is Highly Scalable Pharmacogenomics Research MOUNTAIN VIEW, CA – 23andMe has launched a project funded by the National Institutes of Health (NIH) which is aimed at validating 23andMe’s highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for “Web-based Phenotyping for Genome-Wide […]
Reel-to-reel manufacturing has potential to substantially reduce costs of producing highly multiplexed molecular tests Frederick, MD – Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National […]
SAN DIEGO – Sequenom, Inc. (Nasdaq: SQNM) today announced the acceptance of a manuscript describing results from the R&D “locked-assay” verification study conducted by the company’s wholly-owned subsidiary, Sequenom Center for Molecular Medicine. Details of this study entitled “Noninvasive Detection of Fetal Trisomy 21 by Plasma DNA Sequencing in a Clinical Setting” have been embargoed […]
Intellectual Property Rights Cover Ultrasensitive Detection of Protein Biomarkers to Discover Relationships to Disease States ALAMEDA, Calif. – Singulex, Inc., the leader in high-definition immunodiagnostic technology, announced today that the U.S. Patent & Trademark Office has issued two patents related to the Company’s Erenna® Technology, for the quantitative measurement of single molecules in complex biological […]
BOLOGNA, Italy – Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc. to be headquartered in San Diego, CA. The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics […]
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB). The limitations of traditional smear microscopy, along with the cost and long delays to receive […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
